Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis signal-regulating kinase 1 (ASK1), also known as MAP3K5, is a key serine/threonine kinase that mediates "Reactive oxygen species–sensitive apoptosis signaling" (UniProt: Q99683). It functions as a redox-sensitive molecular switch; in its inactive state, ASK1 is bound to the antioxidant protein thioredoxin (Trx). Upon the accumulation of reactive oxygen species (ROS), Trx becomes oxidized and dissociates, allowing ASK1 to autophosphorylate and activate downstream mitogen-activated protein kinases (MAPKs), specifically JNK and p38 (PubMed: 10409703). This signaling cascade is a critical driver of apoptosis, inflammation, and fibrosis in response to cellular stress. Pathological overactivation of the ASK1 pathway is implicated in several chronic conditions, including non-alcoholic steatohepatitis (NASH), diabetic kidney disease, and various neurodegenerative and cardiovascular diseases (PubMed: 28844882). Consequently, ASK1 has been targeted by pharmaceutical developers using small-molecule inhibitors like selonsertib (GS-4997) to prevent cell death and tissue damage. While early clinical trials showed promise in inflammatory and fibrotic diseases, achieving significant clinical endpoints in late-stage trials has proven challenging (ClinicalTrials.gov: NCT02885350).
Small molecule inhibition of the ASK1 kinase domain to block downstream JNK and p38 MAPK activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis signal-regulating kinase 1 (ASK1) (ASK1).